Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

SUPPORT Aktie 136367563 / JP3322820006

14.07.2026 10:24:57

Tharisa sees price support despite weaker chrome

CHROME concentrate prices have softened in the wake of softer stainless steel demand, partly owing to the Middle East conflict, said Tharisa CEO Phoevos Pouroulis.He was commenting in Tharisa’s third-quarter production update, in which the group remained on target for chrome output of 1.5 to 1.65 million tons (Mt) and platinum group metal production of 145,000 to 165,000 ounces for the year ended September.PGM output increased to 39,600 oz (Q2: 34,300 oz), while chrome output fell to 393,800t from 404,000t, a result of lower milled tons and “a slight” fall in recoveries. The group mined more reef, however, as it recovered from weather-related interruptions during the previous quarter.Chrome prices were “constructive” in the period under review, averaging $306/t, a 5.5% increase on the previous quarter. Said Pouroulis: “Chrome prices remained strong during the reporting period but have since softened, as softer stainless steel demand and cautious mill procurement limited pricing, compounded by prolonged Middle East tensions in a region accounting for approximately 15% of stainless steel consumption.”PGM prices were weaker by about 11%, but at an average price of $2,681/oz they remain at elevated levels year-on-year. “Medium-term fundamentals remain supportive,” said Pouroulis of the PGM market.The market needs to cooperate, for Tharisa is tackling major capital-intensive projects currently, including the underground development of its Tharisa mine in South Africa’s North West province and Karo Platinum, a new-build in Zimbabwe. Capex for the year, including sustaining capex, is set at about $168m.The company ended the third quarter with net cash of $10m, compared with $54.7m at the previous quarter-end – a sign of the capital strain. Over the quarter cash increased to $198.8m (Q2: $184.3m), while debt at $188.1m was about $58m higher.“The reduction in net cash reflects the planned drawdown of the $80m underground transition term loan and increased capital spend across Karo Platinum and the Tharisa underground development during the quarter,” said the group.The post Tharisa sees price support despite weaker chrome appeared first on Miningmx.Weiter zum vollständigen Artikel bei Mining.com
In eigener Sache

Trading Signals: BB Biotech: Comeback nimmt Fahrt auf

Der heimische Biotech-Investor überzeugt nicht nur mit starken Quartalszahlen: Auch schlägt das Portfolio den Branchenindex deutlich, während die Aktie dem inneren Wert noch hinterherhinkt. Genau darin liegt weiteres Kurspotenzial.

Weiterlesen!

Analysen zu SUPPORT Co.,Ltd. Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis

https://bxplus.ch/bx-musterportfolio/

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 15’172.10 19.89 SKUBAU
Short 15’483.24 13.89 SQZB4U
Short 16’050.35 8.99 S7WB3U
SMI-Kurs: 14’552.30 07.08.2026 17:30:00
Long 13’970.23 19.10 S7BGFU
Long 13’678.45 13.83 SCB0YU
Long 13’088.65 8.91 SVB5UU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com